Mereo BioPharma Group PLC (MREO) Stock Price, Quote, News & History

MREONASDAQ
$0.2780
-0.0036-1.28%
At close: Aug 26, 5:00 PM EST
$0.2822
0.00421.51%
After Hours: 7:56 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-25.35M
Investing Cash Flow (TTM)
0
Financing Cash Flow (TTM)
39.00K
Free Cash Flow (TTM)
-25.65M
Capital Expenditure (TTM)
-300.00K
Net Change in Cash (TTM)
-25.31M

Analyst Trends and Forecast

1
Mar
1
May
2
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$15.88M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.57
Earnings Yield % (TTM)
-71.02%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.18

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$30.12M
Debt to Equity
0.04
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$0.29
Close
$0.28
Volume / Avg.
1.02M / 5.57M
Day Range
$0.28 - $0.29
52 Wk Range
0.20 - 2.37
Market Cap
$45.06M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
3.32%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disea...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Mereo BioPharma Group (MREO) stock?

A

You can purchase shares of Mereo BioPharma Group (NASDAQ:MREO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Mereo BioPharma Group (MREO) competitors?

Q

What is the forecast, or price target, for Mereo BioPharma Group (MREO) stock?

A

Mereo BioPharma Group has a consensus price target of $4.58.

Q

What is the current price for Mereo BioPharma Group (MREO)?

A

The stock price for Mereo BioPharma Group (NASDAQ: MREO) is $0.2822 last updated August 26, 2026 at 7:56 PM EDT.

Q

Does Mereo BioPharma Group (MREO) pay a dividend?

A

There are no upcoming dividends for Mereo BioPharma Group.

Q

When is Mereo BioPharma Group (NASDAQ:MREO) reporting earnings?

A

Mereo BioPharma Group does not have any upcoming earnings scheduled.

Q

Is Mereo BioPharma Group (MREO) going to split?

A

There is no upcoming split for Mereo BioPharma Group.

Q

What sector and industry does Mereo BioPharma Group (MREO) operate in?

A

Mereo BioPharma Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.